Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

972 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genome-wide association study identifies CDH13 as a susceptibility gene for rhododendrol-induced leukoderma.
Okamura K, Abe Y, Naka I, Ohashi J, Yagami A, Matsunaga K, Kobayashi Y, Fukai K, Tanemura A, Katayama I, Masui Y, Ito A, Yamashita T, Nagai H, Nishigori C, Oiso N, Aoyama Y, Araki Y, Saito T, Hayashi M, Hozumi Y, Suzuki T. Okamura K, et al. Among authors: aoyama y. Pigment Cell Melanoma Res. 2020 Nov;33(6):826-833. doi: 10.1111/pcmr.12904. Epub 2020 Jun 29. Pigment Cell Melanoma Res. 2020. PMID: 32558222
NGS-based targeted resequencing identified rare subtypes of albinism: Providing accurate molecular diagnosis for Japanese patients with albinism.
Okamura K, Hayashi M, Abe Y, Kono M, Nakajima K, Aoyama Y, Nishigori C, Ishimoto H, Ishimatsu Y, Nakajima M, Hozumi Y, Suzuki T. Okamura K, et al. Among authors: aoyama y. Pigment Cell Melanoma Res. 2019 Nov;32(6):848-853. doi: 10.1111/pcmr.12800. Epub 2019 Jun 9. Pigment Cell Melanoma Res. 2019. PMID: 31141302
Autoantibodies detected in patients with vitiligo vulgaris but not in those with rhododendrol-induced leukoderma.
Arase N, Tanemura A, Jin H, Nishioka M, Aoyama Y, Oiso N, Matsunaga K, Suzuki T, Nishigori C, Kawamura T, Shimizu T, Ito A, Fukai K, Abe Y, Yang L, Tsuruta D, Takeoka K, Iwatani Y, Hidaka Y, Nishida M, Yamauchi-Takihara K, Arase H, Fujimoto M, Katayama I. Arase N, et al. Among authors: aoyama y. J Dermatol Sci. 2019 Aug;95(2):80-83. doi: 10.1016/j.jdermsci.2019.06.009. Epub 2019 Jul 2. J Dermatol Sci. 2019. PMID: 31399283 No abstract available.
2020 guidelines for the diagnosis and treatment of prurigo.
Satoh T, Yokozeki H, Murota H, Tokura Y, Kabashima K, Takamori K, Shiohara T, Morita E, Aiba S, Aoyama Y, Hashimoto T, Katayama I. Satoh T, et al. Among authors: aoyama y. J Dermatol. 2021 Sep;48(9):e414-e431. doi: 10.1111/1346-8138.16067. Epub 2021 Jul 27. J Dermatol. 2021. PMID: 34314056
Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Aihara M, Kano Y, Fujita H, Kambara T, Matsukura S, Katayama I, Azukizawa H, Miyachi Y, Endo Y, Asada H, Miyagawa F, Morita E, Kaneko S, Abe R, Ochiai T, Sueki H, Watanabe H, Nagao K, Aoyama Y, Sayama K, Hashimoto K, Shiohara T; SJS/TEN Study Group. Aihara M, et al. Among authors: aoyama y. J Dermatol. 2015 Aug;42(8):768-77. doi: 10.1111/1346-8138.12925. Epub 2015 May 18. J Dermatol. 2015. PMID: 25982480 Clinical Trial.
Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations.
Takeichi T, Sugiura K, Nomura T, Sakamoto T, Ogawa Y, Oiso N, Futei Y, Fujisaki A, Koizumi A, Aoyama Y, Nakajima K, Hatano Y, Hayashi K, Ishida-Yamamoto A, Fujiwara S, Sano S, Iwatsuki K, Kawada A, Suga Y, Shimizu H, McGrath JA, Akiyama M. Takeichi T, et al. Among authors: aoyama y. JAMA Dermatol. 2017 Jan 1;153(1):66-70. doi: 10.1001/jamadermatol.2016.3601. JAMA Dermatol. 2017. PMID: 27760266
2020 guidelines for the diagnosis and treatment of cutaneous pruritus.
Satoh T, Yokozeki H, Murota H, Tokura Y, Kabashima K, Takamori K, Shiohara T, Morita E, Aiba S, Aoyama Y, Hashimoto T, Katayama I. Satoh T, et al. Among authors: aoyama y. J Dermatol. 2021 Sep;48(9):e399-e413. doi: 10.1111/1346-8138.16066. Epub 2021 Jul 20. J Dermatol. 2021. PMID: 34288036
972 results